Copyright
©The Author(s) 2025.
World J Hepatol. Aug 27, 2025; 17(8): 109801
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.109801
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.109801
Figure 1 Scleral icterus as a biomarker for cirrhosis and advanced liver disease.
Figure 2 Dry eye disease as a biomarker for hepatitis C.
Figure 3 Xanthelasma as a biomarker for cholestatic liver disease.
- Citation: Parmar UPS, Morya AK, Gupta PC, Arora A, Verma N. Role of artificial intelligence-based ocular biomarkers in hepatobiliary diseases: A scoping review. World J Hepatol 2025; 17(8): 109801
- URL: https://www.wjgnet.com/1948-5182/full/v17/i8/109801.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i8.109801